| Esthesioneuroblastoma: prognosis and management. | |
| | |
MedLine Citation:
|
PMID: 8492845 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Forty-nine patients with esthesioneuroblastoma were treated at the Mayo Clinic between 1951 and 1990. Their clinical manifestations and treatment results were reviewed to identify possible prognostic factors. The 5-year survival rate for all patients was 69%. Tumor progression occurred in 25 patients (51%; no local control in 6 and local recurrence in 19). Metastasis was found in 15 patients (31%; regional in 10 and distant in 9). Nineteen patients died directly from metastatic or intracranial tumor extension. The pathological grade of the tumor was the most significant prognostic factor identified. The 5-year survival rate was 80% for the low-grade tumors and 40% for the high-grade tumors (P = 0.0001). Surgical treatment alone is effective for low-grade tumors if tumor-free margins can be obtained. Radiation is used for low-grade tumors when margins are close, for residual or recurrent disease, and for all high-grade cancers. The poor prognosis associated with high-grade tumors may also mandate the addition of chemotherapy. Recurrent tumor and regional metastasis should be treated aggressively because this approach has been shown to be worthwhile. A craniofacial resection is now the surgical procedure performed in all cases. Because recurrence can occur after 5 or even 10 years, long-term follow-up is mandatory. |
| | |
Authors:
|
A Morita; M J Ebersold; K D Olsen; R L Foote; J E Lewis; L M Quast |
Related Documents
:
|
16098355 - Urothelial carcinoma of the upper urinary tract: comparison between the who/isup 1998 c... 10884805 - Neuroendocrine carcinomas (carcinoid tumor) of the thymus. a clinicopathologic analysis... 15338305 - Expression of annexin ii in conventional renal cell carcinoma is correlated with fuhrma... 9192545 - P53 in biopsies of oral squamous cell carcinoma. a comparative study with a malignancy ... 471845 - Nasal skin cancer:hazard to a uniquely exposed structure. 9728615 - Thrombomodulin expression in transitional cell carcinoma. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Neurosurgery Volume: 32 ISSN: 0148-396X ISO Abbreviation: Neurosurgery Publication Date: 1993 May |
Date Detail:
|
Created Date: 1993-06-17 Completed Date: 1993-06-17 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7802914 Medline TA: Neurosurgery Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 706-14; discussion 714-5 Citation Subset: IM |
Affiliation:
|
Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Aged Brain / pathology Brain Neoplasms / drug therapy, pathology, radiotherapy, surgery* Chemotherapy, Adjuvant Child Child, Preschool Combined Modality Therapy Cranial Irradiation Craniotomy Female Follow-Up Studies Humans Male Middle Aged Neoplasm Recurrence, Local / drug therapy, pathology, radiotherapy, surgery Neoplasm Staging Neuroectodermal Tumors, Primitive, Peripheral / drug therapy, pathology, radiotherapy, surgery* Nose / pathology Nose Neoplasms / drug therapy, pathology, radiotherapy, surgery* Prognosis Radiotherapy Dosage |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Stereotactic radiosurgery of cavernous sinus meningiomas as an addition or alternative to microsurge...
Next Document: Primary leptomeningeal melanoma: an unusually aggressive tumor in childhood.